Richmond Pharmacology is pleased to join Swiss Biotech Day 2026 in Basel, Switzerland, on 4-5 May 2026.

Recognised as one of Europe’s leading biotechnology events, Swiss Biotech Day brings together industry pioneers, investors, research institutions, and global life science innovators to explore new partnerships, cutting‑edge technologies, and the future of biotech‑driven healthcare.

Representing Richmond Pharmacology:

  • Dr Jörg Taubel, Chief Executive Officer
  • Stephen Wilkinson, Business Development Manager

Our Focus at the Conference

  • Emerging biotechnology platforms and novel therapeutic innovations
  • Early‑phase clinical development strategies
  • Regulatory, scientific, and partnering insights for global drug development
  • Collaboration opportunities across Europe’s expanding biotech landscape
  • Strengthening scientific, commercial, and translational partnerships

Connect With Us

If you are attending Swiss Biotech Day 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: Home - Swiss Biotech Day

Latest news

Leadership Spotlight- Head of Acute Clinical Management

February 20, 2026
In this edition, we spotlight Carolina Pacheco de Amorim, who leads Acute Clinical Management (ACM)
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event